In addition, 21 days after the tumor-cell injection, the mice treated with the combination of FimH and OVA showed substantially greater OVA-specific IFN-γ production in the tumor-drLN cells by the re-stimulation of the OVA(257–264) and (323–339) peptides than by other treatments (Fig. 4c). The gene discussed is IFNG; the disease is neoplasm.